| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.427 | 43.128 | 58.728 | 40.124 | 64.222 | 44.044 | 184.298 | 244.892 | 116.432 | 86.731 |
| Total Income - EUR | 15.457 | 43.180 | 58.979 | 40.138 | 64.514 | 45.333 | 184.824 | 252.962 | 117.334 | 91.863 |
| Total Expenses - EUR | 4.128 | 10.145 | 25.753 | 15.244 | 45.924 | 21.407 | 111.029 | 157.321 | 53.380 | 49.979 |
| Gross Profit/Loss - EUR | 11.330 | 33.035 | 33.227 | 24.894 | 18.589 | 23.926 | 73.795 | 95.641 | 63.954 | 41.884 |
| Net Profit/Loss - EUR | 10.867 | 31.742 | 31.460 | 23.690 | 16.662 | 22.680 | 70.198 | 93.212 | 62.813 | 40.217 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 4 | 1 |
Check the financial reports for the company - Aspirin Studio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 7.806 | 9.358 | 9.186 | 18 | 0 | 2.983 | 3.702 | 33.157 | 27.374 |
| Current Assets | 11.268 | 35.556 | 64.893 | 92.311 | 108.109 | 128.254 | 80.983 | 98.078 | 65.317 | 51.464 |
| Inventories | 7 | 7 | 7 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 336 | 15.643 | 45.025 | 81.927 | 104.760 | 125.641 | 73.453 | 84.786 | 63.157 | 36.996 |
| Cash | 10.925 | 19.906 | 19.862 | 10.378 | 3.349 | 2.613 | 7.530 | 13.291 | 2.160 | 14.468 |
| Shareholders Funds | 10.912 | 42.542 | 73.282 | 95.627 | 105.934 | 126.606 | 70.247 | 93.260 | 62.862 | 40.230 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 356 | 821 | 969 | 5.870 | 2.193 | 559 | 13.275 | 8.214 | 32.637 | 38.607 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.089 | 445 | 306 | 3.269 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7410 - 7410" | |||||||||
| CAEN Financial Year |
5911
|
|||||||||
Comments - Aspirin Studio S.r.l.